HOME >> BIOLOGY >> NEWS
Wildfire suppression costs may be reduced using new model

Portland, Ore. June 28, 2006. Recent research shows that using the right mix of agency and contract crews is the most cost effective way to fight fires rather than using contract or agency crews exclusively, according to Geoffrey Donovan, a research forester at the Forest Service's Pacific Northwest Research Station.

Donovan arrived at these findings after analyzing the full cost of 33 Forest Service type II fire crews dispatched during the 2003 fire season from five national forests in Oregon and Washington. The costs were estimated and compared with the cost of contract crews dispatched in the same region.

"My model helps managers to reduce costs by finding the optimal mix of contract and agency crews," explains Donovan. "A comparison of the full cost of a contract and an agency crew shows that if an agency crew is provided with continuous work, then the cost of that crew is approximately 70 percent of the cost of a contract crew. However, if an agency crew is not provided with continuous work, then it quickly loses its cost advantage."

The model so far, is applicable only to Oregon and Washington, although the methodology can be applied in other areas of the country. The entire study appears in the Western Journal of Applied Forestry and in the research publication, Ecological Modeling.

Wildfire suppression costs in the West and across the country have increased dramatically in the past 10 years. Public land managers are struggling with shrinking budgets, rising costs for personnel and equipment, and higher demand for services from rural communities. As a result, the Forest Service is increasingly relying on contract fire crews and using fewer agency fire crews.


'"/>

Contact: Sherri Richardson Dodge
srichardsondodge@fs.fed.us
503-808-2137
USDA Forest Service, Pacific Northwest Research Station
28-Jun-2006


Page: 1

Related biology news :

1. Wildfires and home prices: Are they related?
2. Natural mechanism for immune suppression paves way for cancer trials
3. Oxidative stress stimulates p38 MAPK-mediated tumor suppression
4. Scripps Research study reveals new function of protein kinase pathway in tumor suppression
5. Transplant cures rats type 2 diabetes without need for immune suppression drugs
6. UCSF study shows suppression of telomerase enzyme can inhibit spread of melanoma
7. p53, tumor suppression and aging
8. Researchers find a potential key to human immune suppression in space
9. Researchers find BRCA1 tumor suppression nullified by cyclin D1
10. BRCA1 tumor suppression nullified by cyclin D1 at the estrogen receptor
11. Gene changes linked to deficient immune suppression in MS

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/8/2017)... YORK , Feb. 8, 2017 About ... individual,s voice to match it against a stored ... such as pitch, cadence, and tone are compared ... require minimal hardware installation, as most PCs already ... for different transactions. Voice recognition biometrics are most ...
(Date:2/7/2017)... MINNETONKA, Minn. , Feb. 7, 2017   ... that supports the entire spectrum of clinical research, is ... iMedNet , its innovative, highly flexible and ... iMedNet customers. iMedNet is a ... only provides Electronic Data Capture (EDC), but also delivers ...
(Date:2/3/2017)... Feb. 3, 2017 A new independent identity ... Partners, LLP (IdSP) . Designed to fill a critical ... identity market, founding partners Mark Crego and ... years just in identity expertise that span federal governments, ... leadership. The Crego-Kephart combined expertise has a common theme ...
Breaking Biology News(10 mins):
(Date:2/17/2017)... 17, 2017  Protagonist Therapeutics, Inc. (NASDAQ: PTGX) ... oral peptide drug candidates, PTG-100 and PTG-200, at ... Crohn,s and Colitis Organization (ECCO).  The ECCO congress ... from February 15 – 18, 2017. ... on Protagonist drug candidates PTG-100 and PTG-200. PTG-100, ...
(Date:2/16/2017)... GREENWICH, Conn. , Feb. 16, ... focused on venture growth investments in biotechnology and ... Josh Richardson , M.D. to Managing Director. ... companies.  He is a board observer at InfaCare ... Longitude,s investments in Aimmune Therapeutics, Akebia Therapeutics, Cadence ...
(Date:2/16/2017)... 2017   Capricor Therapeutics, Inc. (NASDAQ: ... developing first-in-class biological therapies for cardiac and other ... to terminate its license agreement with the Mayo ... Cenderitide. "Our decision to return these ... our efforts to advance our core cell and ...
(Date:2/16/2017)... Feb. 16, 2017  Dermata Therapeutics, LLC, a ... treat a variety of dermatological diseases, today announced ... financing and entered into a $5 million credit ... to use the capital for general corporate purposes ... in the treatment of serious diseases treated by ...
Breaking Biology Technology:
Cached News: